Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson's disease - ScienceDirect
PDF) Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson`s disease patients
The efficacy and safety of pramipexole ER versus IR in Chinese patients with Parkinson's disease: a randomized, double-blind, double-dummy, parallel-group study | Translational Neurodegeneration | Full Text